Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy.
about
How we manage autologous stem cell transplantation for patients with multiple myelomaPlerixafor for mobilization of blood stem cells in autologous transplantation: an update.Cyclophosphamide-based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial ReLApsE.Plerixafor injection: a hematopoietic stem cell mobilizer in non-Hodgkin lymphoma and multiple myeloma.Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies.Pre-emptive plerixafor injection in lymphoma patients mobilized with chemotherapy plus pegfilgrastim followed by apheresis on the same day.
P2860
Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Phase 2 trial of intravenously ...... idomide-based initial therapy.
@ast
Phase 2 trial of intravenously ...... idomide-based initial therapy.
@en
type
label
Phase 2 trial of intravenously ...... idomide-based initial therapy.
@ast
Phase 2 trial of intravenously ...... idomide-based initial therapy.
@en
prefLabel
Phase 2 trial of intravenously ...... idomide-based initial therapy.
@ast
Phase 2 trial of intravenously ...... idomide-based initial therapy.
@en
P2093
P2860
P356
P1476
Phase 2 trial of intravenously ...... idomide-based initial therapy.
@en
P2093
A K Stewart
D A Gastineau
J L Winters
L P Bergsagel
P2860
P2888
P304
P356
10.1038/BMT.2013.175
P407
P577
2013-11-04T00:00:00Z
P5875
P6179
1029517299